RT Journal Article
SR Electronic
T1 ▼Perampanel: a new add-on treatment for epilepsy
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 18
OP 20
DO 10.1136/dtb.2013.1.0159
VO 51
IS 2
YR 2013
UL http://dtb.bmj.com/content/51/2/18.abstract
AB ▼Perampanel (Fycompa – Eisai) is a new antiepileptic drug marketed in the EU. It is licensed for use as adjunctive treatment of partial-onset seizuresi with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.2 Here we discuss the place of perampanel in the treatment of epilepsy.